Perfinity Biosciences, Inc. — Form D
Perfinity Biosciences, Inc. of WEST LAFAYETTE, IN, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-29. The offering totals $2.5M, of which $2.3M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2010-06-29
- Form: D
- Accession: 0001178858-10-000005
- Industry: Manufacturing
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $2.3M
- Remaining: $171K
- Minimum investment: $1K
- Investors: 22
- Date of first sale: 2010-06-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-144164
Issuer
- Name: Perfinity Biosciences, Inc.
- CIK: 0001488641
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 3000 KENT AVENUE, WEST LAFAYETTE, IN, 47906
- Phone: (765) 775-1026
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Frank P Cheng | Director | West Lafayette, IN |
| Michael A Evans | Director | Indianapolis, IN |
| Timothy R Franson | Director | San Diego, CA |
| Stephen P Hokanson | Director | West Lafayette, IN |
| R. Matthew Neff | Director | Indianapolis, IN |
| Drew F Peyronnin | Director | West Lafayette, IN |
| Fred F Regnier | Director | West Lafayette, IN |
| Stephen P Hokanson | Executive Officer | West Lafayette, IN |
| Steven Plump | Executive Officer | West Lafayette, IN |
Other filings by this issuer (1)
More